Clinical Trials Browser

Phase 1 × Has announcements × trastuzumab deruxtecan × Clear all

NCT02564900 2024-01-22

Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors

Phase 1 Completed

292 enrolled 35 charts 1 FDA

Neoplasms